GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00515605 | Liver | NAFLD | mitochondrial calcium ion homeostasis | 8/1882 | 26/18723 | 3.06e-03 | 2.75e-02 | 8 |
GO:00068397 | Liver | Cirrhotic | mitochondrial transport | 112/4634 | 254/18723 | 1.03e-11 | 6.66e-10 | 112 |
GO:005156011 | Liver | Cirrhotic | mitochondrial calcium ion homeostasis | 15/4634 | 26/18723 | 3.43e-04 | 2.93e-03 | 15 |
GO:19905425 | Liver | Cirrhotic | mitochondrial transmembrane transport | 41/4634 | 102/18723 | 4.08e-04 | 3.37e-03 | 41 |
GO:00364444 | Liver | Cirrhotic | calcium import into the mitochondrion | 8/4634 | 14/18723 | 9.65e-03 | 4.35e-02 | 8 |
GO:000683912 | Liver | HCC | mitochondrial transport | 184/7958 | 254/18723 | 2.30e-22 | 3.83e-20 | 184 |
GO:199054212 | Liver | HCC | mitochondrial transmembrane transport | 78/7958 | 102/18723 | 2.73e-12 | 1.26e-10 | 78 |
GO:003644411 | Liver | HCC | calcium import into the mitochondrion | 13/7958 | 14/18723 | 1.25e-04 | 1.03e-03 | 13 |
GO:005156021 | Liver | HCC | mitochondrial calcium ion homeostasis | 20/7958 | 26/18723 | 3.82e-04 | 2.61e-03 | 20 |
GO:00068513 | Liver | HCC | mitochondrial calcium ion transmembrane transport | 16/7958 | 20/18723 | 7.15e-04 | 4.37e-03 | 16 |
GO:000683928 | Thyroid | PTC | mitochondrial transport | 150/5968 | 254/18723 | 2.76e-19 | 3.34e-17 | 150 |
GO:199054225 | Thyroid | PTC | mitochondrial transmembrane transport | 57/5968 | 102/18723 | 4.49e-07 | 7.38e-06 | 57 |
GO:00068515 | Thyroid | PTC | mitochondrial calcium ion transmembrane transport | 16/5968 | 20/18723 | 1.31e-05 | 1.42e-04 | 16 |
GO:00515608 | Thyroid | PTC | mitochondrial calcium ion homeostasis | 19/5968 | 26/18723 | 1.93e-05 | 1.98e-04 | 19 |
GO:00364446 | Thyroid | PTC | calcium import into the mitochondrion | 12/5968 | 14/18723 | 4.96e-05 | 4.42e-04 | 12 |
GO:000683929 | Thyroid | ATC | mitochondrial transport | 151/6293 | 254/18723 | 2.07e-17 | 2.14e-15 | 151 |
GO:199054226 | Thyroid | ATC | mitochondrial transmembrane transport | 57/6293 | 102/18723 | 3.05e-06 | 3.49e-05 | 57 |
GO:000685111 | Thyroid | ATC | mitochondrial calcium ion transmembrane transport | 16/6293 | 20/18723 | 2.79e-05 | 2.36e-04 | 16 |
GO:005156014 | Thyroid | ATC | mitochondrial calcium ion homeostasis | 19/6293 | 26/18723 | 4.49e-05 | 3.61e-04 | 19 |
GO:003644412 | Thyroid | ATC | calcium import into the mitochondrion | 12/6293 | 14/18723 | 8.96e-05 | 6.59e-04 | 12 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MICU3 | SNV | Missense_Mutation | | c.757N>A | p.Asp253Asn | p.D253N | Q86XE3 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A2-A0SW-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | arimidex | PD |
MICU3 | SNV | Missense_Mutation | | c.1072N>C | p.Glu358Gln | p.E358Q | Q86XE3 | protein_coding | tolerated(0.11) | benign(0.036) | TCGA-E2-A14Y-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD |
MICU3 | SNV | Missense_Mutation | | c.826N>C | p.Asp276His | p.D276H | Q86XE3 | protein_coding | deleterious(0.05) | benign(0.417) | TCGA-E2-A15T-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
MICU3 | insertion | Frame_Shift_Ins | novel | c.790_791insA | p.Phe264TyrfsTer6 | p.F264Yfs*6 | Q86XE3 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MICU3 | insertion | Nonsense_Mutation | novel | c.792_793insCTTTGGTATTGGTAACCCATAATTA | p.Arg265LeufsTer5 | p.R265Lfs*5 | Q86XE3 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MICU3 | deletion | Frame_Shift_Del | | c.425delN | p.Thr143HisfsTer13 | p.T143Hfs*13 | Q86XE3 | protein_coding | | | TCGA-D8-A146-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MICU3 | SNV | Missense_Mutation | rs751018914 | c.838N>T | p.Arg280Cys | p.R280C | Q86XE3 | protein_coding | deleterious(0.03) | benign(0) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
MICU3 | SNV | Missense_Mutation | | c.1108N>C | p.Glu370Gln | p.E370Q | Q86XE3 | protein_coding | deleterious(0) | probably_damaging(0.943) | TCGA-EK-A2RJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
MICU3 | SNV | Missense_Mutation | | c.835N>G | p.Lys279Glu | p.K279E | Q86XE3 | protein_coding | deleterious(0.04) | benign(0.046) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
MICU3 | SNV | Missense_Mutation | rs201654618 | c.449N>A | p.Arg150His | p.R150H | Q86XE3 | protein_coding | tolerated(0.55) | benign(0.137) | TCGA-MA-AA3Y-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |